Tamir Shragai

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Patient Reported Outcomes

Ejection Fraction

Multiple Myeloma

Acute Lymphoblastic Leukemia

Top Venues

British journal of haematology

European journal of haematology

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Irit Avivi, Naama Yekutiel, Tamir Shragai, Yael C Cohen, Moshe Grunspan, Noa Rivlin, Neta Frankel, Raanan Cohen, Clara Weil, Gabriel Chodick
Management and outcome of 500 multiple myeloma patients treated for first relapse outside clinical studies. Annals of hematology (2023)
Irit Avivi, Tamir Shragai, Efrat Luttwak, Svetlana Trestman, Yael C Cohen
Treatment with low-dose, single-agent belantamab mafodotin is safe and provides long-term responses in heavily pretreated multiple myeloma patients. European journal of haematology (2023)
Tamir Shragai, Hila Magen, Noa Lavi, Moshe E E Gatt, Svetlana Trestman, Miri Zektser, Chezi Ganzel, Osnat Jarchowsky, Tamar Berger, Tamar Tadmor, Merav Leiba, Katrin Hertzog-Tzarfaty, Netanel Horowitz, Michael Shapira, David Varssano, Yoav Berger, Shahar Frenkel, Mark Krauthammer, Irit Avivi, Efrat Luttwak, Yael C Cohen, null null
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study. British journal of haematology (2022)
Irit Avivi, Roi Balaban, Tamir Shragai, Gabi Sheffer, Miguel Morales, Anat Aharon, Noa Lowenton-Spier, Svetlana Trestman, Chava Perry, Noam Benyamini, Moshe Mittelman, Yaara Tabib, Tali Bar Lev, Mor Zavaro, Yair Herishanu, Efrat Luttwak, Yael C Cohen
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myeloma. British journal of haematology 195 (2) (2021)
Tamir Shragai, Eyal Lebel, Dana Deshet, David Varon, Irit Avivi, Ilya Kirgner, Nadav Sarid
Characteristics and outcomes of adults with cytomegalovirus-associated thrombocytopenia: a case series and literature review. British journal of haematology 191 (5) (2020)
Tamir Shragai, Moshe E E Gatt, Noa Lavie, Iuliana Vaxman, Tamar Tadmor, Ory Rouvio, Miri Zektser, Nethanel Horowitz, Hila Magen, Mouna Ballan, Celia Suru, Efrat Luttwak, Shai Levi, Tomer Ziv-Baran, Irit Avivi, Yael C Cohen
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review. European journal of haematology 106 (2) (2020)